Literature DB >> 24671588

Effects of calcium salts of soybean oil on factors that influence pregnancy establishment in Bos indicus beef cows.

R F Cooke1, B I Cappellozza, T A Guarnieri Filho, C M Depner, K A Lytle, D B Jump, D W Bohnert, R L A Cerri, J L M Vasconcelos.   

Abstract

The objective of this experiment was to compare fatty acid (FA) concentrations in plasma and reproductive tissues as well as hormones and expression of genes associated with pregnancy establishment in beef cows supplemented or not with Ca salts of soybean oil (CSSO) beginning after timed AI. Ninety nonlactating multiparous Nelore (Bos indicus) cows were timed inseminated on d 0 of the experiment and divided into 18 groups of 5 cows/group. Groups were randomly assigned to receive (as-fed basis) 100 g of a protein-mineral mix plus 100 g of ground corn per cow daily in addition to 1) 100 g/cow daily of CSSO (n = 9) or 2) 100 g/cow daily of kaolin (CON; rumen-inert indigestible substance; n = 9). All groups were maintained in a single Brachiaria brizanta pasture (24 ha) with ad libitum access to forage and water. However, groups were segregated daily and offered treatments individually at the working facility during the experimental period (d 0 to 18). Blood samples were collected and transrectal ultrasonography was performed to verify ovulation and estimate corpus luteum (CL) volume immediately before AI (d 0) and on d 7 and 18 of the experiment. On d 19, 36 cows (18 cows/treatment; 2 cows/group) diagnosed without the presence of a CL on d 0 but with a CL greater than 0.38 cm(3) in volume on d 7 and 18 were slaughtered for collection of conceptus, uterine luminal flushing, and tissue samples from the CL and endometrium. Cows receiving CSSO had greater concentrations of linoleic and other ω-6 FA in plasma (P < 0.01), endometrium (P ≤ 0.05), CL (P ≤ 0.05), and conceptus (P ≤ 0.08) compared to CON. On d 7 of the experiment, CSSO-supplemented cows had greater plasma progesterone concentrations (P < 0.01) and CL volume (P = 0.02) compared to CON, whereas no treatment effects were detected (P ≥ 0.15) for these parameters on d 18 (treatment × day interaction; P < 0.01). Cows receiving CSSO tended (P = 0.09) to have greater concentrations of interferon-tau in the uterine flushing media compared with CON. However, no treatment effects were detected for mRNA expression genes associated with pregnancy establishment in endometrial, CL, and conceptus samples (P ≥ 0.12). In summary, supplementing beef cows with 100 g of CSSO beginning after AI favored incorporation of ω-6 FA into their circulation, reproductive tissues, and conceptus, without impacting expression of genes associated with pregnancy establishment on d 19 of gestation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24671588     DOI: 10.2527/jas.2013-7422

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  3 in total

1.  Impacts of estrus expression and intensity during a timed-AI protocol on variables associated with fertility and pregnancy success in Bos indicus-influenced beef cows.

Authors:  A D Rodrigues; R F Cooke; R S Cipriano; L G T Silva; R L A Cerri; L H Cruppe; M Meneghetti; K G Pohler; J L M Vasconcelos
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

2.  Supplementing Ca salts of soybean oil after artificial insemination increases pregnancy success in Bos taurus beef cows.

Authors:  Alice P Brandão; Reinaldo F Cooke; Kelsey M Schubach; Rodrigo S Marques; David W Bohnert; Rafael S Carvalho; Nicholas W Dias; Claire L Timlin; Sherrie Clark-Deener; John F Currin; Donald B Jump; Ky G Pohler; Ronaldo L A Cerri; Vitor R G Mercadante
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

3.  Early career achievement award: supplementing omega-6 fatty acids to enhance early embryonic development and pregnancy establishment in Bos indicus and B. taurus beef cows.

Authors:  Reinaldo F Cooke
Journal:  J Anim Sci       Date:  2019-01-01       Impact factor: 3.159

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.